Agilent Technologies, Inc. (A) Misses Q2 EPS by 4c; Guides Below The Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts A Hot Sheet
Price: $178.28 +1.61%
EPS Growth %: +8.8%
Financial Fact:
Total costs and expenses: 888M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: +8.8%
Financial Fact:
Total costs and expenses: 888M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Agilent Technologies, Inc. (NYSE: A) reported Q2 EPS of $0.79, $0.04 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.79 billion.
Agilent Technologies, Inc. sees FY2012 EPS of $3.06-3.08, versus the consensus of $3.23. Agilent Technologies, Inc. sees FY2012 revenue of $6.85-6.87 billion, versus the consensus of $7.03 billion.
For earnings history and earnings-related data on Agilent Technologies, Inc. (A) click here.
Agilent Technologies, Inc. sees FY2012 EPS of $3.06-3.08, versus the consensus of $3.23. Agilent Technologies, Inc. sees FY2012 revenue of $6.85-6.87 billion, versus the consensus of $7.03 billion.
For earnings history and earnings-related data on Agilent Technologies, Inc. (A) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agilent acquires Proscia for $240M in digital pathology deal
- Berkshire Hathaway hits 52-week high on election rally
- VivoPower posts $6.8M revenue and $0.6M profit in Q1 FY2027
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
